The ENTR ETF: Once Incurable Maladies Now Within Reach

The healthcare sector has been solid in 2020, but the truly impressive gains are coming by way of the companies disrupting the industry. Investors looking to access high-flying names such as CRISPR Therapeutics (NASDAQ: CRSP) and Twist Bioscience (NASDAQ: TWST) should consider innovative strategies such as the Entrepreneur 30 Fund ( ENTR ).